Abstract: The FET sub-family (FUS/TLS, EWS, TAF15) of RNA-binding proteins have remarkably similar overall structure but diverse biological and pathological roles. The molecular basis for FET protein specialization is largely unknown. Gly-Arg-Rich regions (RGG-boxes) within FET proteins are targets for methylation by Protein-Arginine-Methyl-Transferase-1 (PRMT1) and substrate capture is thought to involve electrostatic attraction between positively charged polyRGG substrates and negatively charged surface channels of PRMT1. Unlike FUS and EWS, a high proportion of TAF15 RGG-boxes are embedded within neutrally charged YGGDR(S/G)G repeats, suggesting that they might not bind well to PRMT1. This notion runs contrary however to a report that YGGDR(S/ G)G repeats are methylated by PRMT1. Using peptide-based polyRGG substrates and a novel 2-hybrid binding assay, we find that the Asp residue in YGGDR(S/G)G repeats confers poor binding to PRMT1. Our results therefore indicate that YGGDR(S/G)G repeats may contribute to TAF15 specialization by enabling differential interactions with PRMT1 and reduced overall levels of TAF15 methylation compared with other FET proteins. By analogy with molecular recognition of other disordered polyvalent ligands by globular protein partners, we also propose a dynamic polyelectrostatic model for substrate capture by PRMT1.
Introduction
FET proteins (FUS, EWS, TAF15, Fig. 1 ) are members of the RNP family of RNA-binding proteins that are widely expressed in different tissues, present in many subcellular compartments and involved in several aspects of gene expression/regulation. [1] [2] [3] Accordingly FET proteins have diverse biological roles and are implicated in several diseases. [2] [3] [4] [5] Biochemically and structurally, FET proteins contain an n-terminal transcriptional activation domain (EAD) and a c-terminal RNA-bindingdomain (RBD). EAD has largely been characterized in Ewings family oncoproteins (EFPs) arising from chromosomal translocations 6 and the role of EAD in native FET proteins remains obscure. In contrast FET RBD function is central to the role of FET proteins in different aspects of RNA biogenesis. [1] [2] [3] Although FET family members have remarkably similar structure and overlapping expression patterns 7, 8 they are not functionally redundant. However, the molecular basis underlying FET specialization has not been extensively studied. Relevant to the current study, the intrinsically disordered Gly-Arg-Rich (GAR) regions or RGG-boxes 9 of TAF15 are embedded in highly reiterated YGGDR(G/S)GG repeats that are not present in FUS and EWS ( Fig. 1 ) and that may therefore enable functional differentiation of TAF15. 10 Protein-Arginine-Methyl-Transferases (PRMTs) bind to and methylate GAR regions of many proteins 11 including RGG-boxes in EWS and TAF15. [12] [13] [14] [15] [16] [17] Methylation generally impacts FET protein levels and subcellular location 18 but other effects vary for different FET proteins. 15, 17 Furthermore the role of particular PRMTs in FET methylation may be complex. Most RGG-boxes in both EWS and TAF15 are reportedly substrates for PRMT1 14, 17 while PRMT3
and PRMT8 interact only with a subset of RGG-boxes in EWS. 14, 16, 19 Furthermore, several other PRMTs bind to but do not methylate EWS 16 perhaps suggesting an expanded role for PRMTs in FET function/ regulation. The molecular mechanism for polyRGG methylation by PRMT1 involves catalysis at the active site 11 and less well characterized longer range interactions required for substrate capture. Regarding the latter aspect it has been suggested that positively charged substrates engage in electrostatic interactions with negatively charged residues in shallow surface binding channels of PRMT1. [20] [21] [22] This mechanism may be supported by systematic substrate profiling which showed that fibrillarinbased peptides with Asp residues immediately cterminal to Arg are poor PRMT1 substrates. 23 With respect to FET proteins, neutrally charged TAF15 substrates harboring YGGDR(S/G)G repeats might be expected to bind poorly to PRMT1. However, a report that several Arg residues present in TAF15 YGGDR(G/S)G repeats are methylated by PRMT1 in vivo runs contrary to this notion. 17 In addition, the potential effect of aromatic residues in the preferred RGG-box methylation site consensus F/GGGRGGG/ F 24 or in TAF15 YGGDR(G/S)G repeats has yet to be scrutinized.
We have directly examined the interaction of PRMT1 with an extensive panel of polyRGG-box substrates. We report that substrate aromatics (Phe or Tyr) are either neutral or promote binding to PRMT1, while sufficient numbers of substrate Asp residues impairs binding/methylation. Considering their prevalence specifically in TAF15, the above finding strongly suggest that YGGDR(S/G)G repeats contribute to TAF15 specialization by allowing differential interactions with PRMT1 and reducing overall levels of TAF15 methylation. Our results also extend understanding of molecular recognition of polyRGG substrates by PRMT1, and we propose a dynamic polyelectrostatic mechanism for substrate capture.
Results

Peptides containing TAF15 YGGDR(S/G)G repeats are poor substrates for PRMT1
Previous studies have shown that PRMT1 methylates multiple Arg residues within the RGG rich regions (RGG1-3, Fig. 1 ) of the FET family members EWS 12, 15 and TAF15. 13, 17 However, TAF15 has a high proportion of unique RGG-boxes embedded in YGGDR(S/G)G repeats [ Fig. 1 (A)] and these repeat motifs can be functionally differentiated from other RGG-boxes. 10 Using polyRGG substrates we therefore sought to test directly whether YGGDR(S/G)G repeats affect methylation by PRMT1. Initially we employed an in vitro methylation assay using a Gst-PRMT1 affinity resin and histidine-tagged Gal4-VP16 (G4VP16) derivatives 25 containing various reiterated EWS or TAF15 RGGboxes. The amount of total input substrates was monitored by Coomassie Blue staining of SDS gels and methylation of bound proteins was detected following SDSPAGE and autoradiography of labeled substrates following incorporation of radiolabel from Fig. 1(B) ]. The G4VP16 vector protein gave no significant signal while methylation was observed for the corresponding protein (GVSR4) containing multiple RGG-boxes present within a peptide (SR4) from the RGG3 region of EWS [ Fig.  1(B) ]. As a control for specificity changing Arg to Ala within the SR4 peptide (GVSRm1) eliminated radiolabeling, thus confirming the requirement of Arg residues for methylation in this assay. We next tested a protein (GVSR2) containing RGG-boxes from the RGG1 region of EWS [ Fig. 1(A) ] and found that GVSR2 methylation was comparable to GVSR4 [ Fig. 1(B) ]. Methylation of both EWS peptides (SR4 and SR2) was comparable to several other known PRMT1 substrates Sam68, 26 SAF-A, 27 and Frmp, 28 indicating that it is efficient (data not shown).
Next we tested a TAF15 peptide (T15R) containing only YGGDRGG repeats. T15R alone was poorly methylated and was not detectably methylated when present together with SR4 [ Fig. 1(B) ]. Thus, T15R is a very poor substrate for PRMT1. It should be stressed that under our assay conditions lack of T15R methylation might reflect poor catalysis, poor binding to PRMT1 or both (see below). Given the common association of aromatic residues (usually Phe but which can be substituted by Tyr, see Fig. 3 ) with many other RGG-boxes, 24 the above result suggests that the Asp residue in YGGDR(S/G)G repeats renders T15R a poor PRMT1 substrate. Similar to the T15R peptide, many other RGG-rich peptides [C2-C4, Fig. 1(A) ] within the RGG3 region of TAF15 have Asp residues adjacent to Arg, suggesting that they might also be poor PRMT1 substrates. We were unable to test C2-C4 peptides in the pull-down assay due to problems with bacterial protein solubility/purification. However, C2-C4 were tested for PRMT1 binding in the 2-hybrid assay (see Fig. 3 ) and they bind PRMT1 an order of magnitude less well than SR4. For the remaining TAF15 RGG-boxes [those in peptides C5-C7, Fig. 1 (A)] we tested all of them together in one protein (GVRD) and observed only weak methylation by PRMT1 [ Fig. 1(B) ]. The total number of Arg residues present in the RD peptide is 28 and thus exceeds the 16 Arg (present in SR4 and SR2) that suffice for methylation in the in vitro assay. To determine whether any of the RGGrich sub-regions present in RD could be methylated by PRMT1, we tested peptides C5 alone, C6 alone and C7 alone (all in the presence of SR4 as internal control). Of the above peptides only C6 was strongly methylated by PRMT1 [ Fig. 1 (B)] consistent with other studies showing that PRMT1 methylates TAF15. 13, 17 When tested in the absence of SR4, both C5 and C7 peptides behaved similarly to T15R and were poorly methylated (data not shown). In summary, the in vitro methylation results indicate that several RGG-rich sub-regions of TAF15 are poor PRMT1 substrates.
A derivative 2-hybrid assay for binding of PRMT1 to polyRGG substrates
The inability of PRMT1 to methylate neutrally charged peptides containing YGGDRGG repeats is consistent with idea that the positive charge of other polyRGG substrates is important for binding to PRMT1 (11) . On the other hand, a previous in vivo study reported that PRMT1 methylates multiple TAF15 RGG-boxes within YGGDRGG repeats. 17 We therefore devised a novel 2-hybrid assay ( Fig. 2) to corroborate results from the in vitro methylation assay and also to allow examination of substrate capture rather than catalysis/methylation. Mammalian Jeg3 cells were co-transfected with a CAT transcriptional reporter (Z7E4TCAT or Zta-CAT) containing multiple Zta binding sites, a bait plasmid expressing a PRMT1/Zta fusion protein (pPRMT1Z) and prey plasmids expressing reiterated RGG-box variants/mutants fused to the EWS (EAD) and VP16 trans-activation domains and the Gal4 DNA-binding-domain. Utilization of a double activation domain in the prey is required because RGGboxes repress either activation domain alone (thus precluding a classical 2-hybrid assay) but a combination of EAD and VP16 overcomes this repression and thus allows scoring of PRMT1/RGG-box binding. 29 Accordingly the presence of a prey containing the reiterated EWS SR4 peptide results in strong activation of the Zta-CAT reporter (reflecting PRMT1/SR4 binding) dependent on PRMT1/Zta (Fig.  2) . The PRMT1/SR4 interaction is specific as indicated by the effects of changing Arg to Ala (SRm1) and Arg to Lys in SR4 (SRm2) with both changes strongly impairing binding to PRMT1 (Fig. 2) . Changing Phe residues within SR4 to Ala (SRm3) also impaired PRMT1 binding indicating that Phe residues, often associated with methylated RGGboxes, 24 are required for SR4 peptide binding to PRMT1. The above requirement is not universal, however, since several effective PRMT1 substrates including histone H4 Arg3, 30 Sam68, 26 and Frmp 28 lack Phe/aromatic residues.
The presence of Asp residues in polyRGG substrates impairs binding to PRMT1
We employed the mammalian cell 2-hybrid assay to ask whether substrates that are poorly methylated in vitro are defective for binding to PRMT1 in vivo (Fig. 3) . Firstly the EWS SR2 peptide bound well to PRMT1 (71% of SR4) while T15R binding was close to background levels (3% of SR4), consistent with results from the in vitro methylation assay [ Fig.  1(B) ]. The presence of the Gal4 DNA-bindingdomain in prey proteins (see Fig. 2 ) enabled direct testing of trans-activation of a Gal4-CAT reporter, thus ruling out false negative results for PRMT1 binding. Accordingly the ability of GVT15R protein to activate Gal4CAT to the same level as GVSR4, demonstrates that GVT15R is expressed, present in the nucleus and functional for transcription but unable to bind PRMT1. Next we tested the TAF15 peptides C2-C4, all of which, like T15R, have a universal Asp residue immediately n-terminal to all Arg residues (Fig. 3) . C2 exhibited only background levels of PRMT1 binding (4% of SR4), while C3 (8% of SR4) and C4 (11% of SR4) showed weak although detectable binding. All three proteins (C2-C4) were fully functional for activation of Gal4CAT (Fig. 3) . Finally we tested a series of mutants to establish the basis for the inability of T15R and C2-C4 peptides to bind PRMT1 (Fig. 3) . Insertion of a Ser residue adjacent to each Arg in SR4 (ERS) mimics the Ser present in TAF15 C2 but had no effect on PRMT1 binding. Thus, the Ser residue present in C2 (and to a lesser degree in C4) does not account for lack of PRMT1 binding by C2 or C4. Similarly, substitution of both Phe residues in SR4 with Tyr (EFY) or insertion of additional Tyr residues into SR4 (EPY) had no effect on PRMT1 binding, indicating that Tyr residues in C2-C4 (or T15R) do not account for lack of PRMT1 binding. This latter result is consistent with the positive effect of Phe on SR4 binding to PRMT1 (Fig. 2) . Finally, addition of Asp residues to SR4 together with Tyr (EPYD) or Gly (EPGD), in both cases reduced PRMT1 binding to background levels, while changing Asp in TF15R to Ala (T15DA) allowed PRMT1 binding. In summary, of 12 poly-RGG substrates tested, six lack Asp and bind to PRMT1 while the other six contain Asp and do not bind. Thus, we conclude that the presence of Asp residues in polyRGG peptides impairs binding to PRMT1.
Discussion
Using peptide-based assays we report that the Asp residue present within TAF15 YGGDR(S/G)G repeats significantly impairs methylation by PRMT1. This effect is at least partly due to poor substrate capture by PRMT1 (see Fig. 4 and discussion below). With respect to catalysis, the active site pocket of all PRMTs contain a pair of conserved acidic Glu residues (the double-E loop) that provide a negative charge to coordinate the substrate Arg for catalysis. 31 It seems likely that the above interaction (and hence catalysis) would also be antagonized by Asp residues present in YGGDR(S/G)G repeats but our data do not address this. We have not examined interaction between PRMT1 and native TAF15 and this issue warrants consideration in light of contextual effects that can influence PRMT1-mediated methylation. 23 As described above we cannot make any inferences regarding the potential effect of Asp residues on catalysis for YGGDR(S/G)G substrates. However, the binding properties of several natural and derivative EWS and TAF15 substrates, their polyvalency (typically harboring 16 RGG-boxes) and the high level of intrinsic disorder within GAR regions 6 and overall in native FET proteins, 6, 32 together strongly suggest that YGGDR(S/ G)G repeats in native TAF15 would bind poorly to PRMT1 and would thus be poorly methylated. Our findings should also be reconciled with a previous report that PRMT1 methylates a significant proportion of TAF15 RGG-boxes including many present within YGGDR(S/G)G repeats. 17 First, Figure 3 . Testing SR4 and T15R derivatives. 2-hybrid assays and data presentation are as described in Figure 2 , with SR4 and T15R as positive and negative references, respectively. The location of all natural EWS and TAF15 peptides is shown in Figure  1 (A). T15DA corresponds to T15R with all Asp residues changed to Ala. All other peptides (EFY, EPY, EPYD, EPGD, and ERS) are derivatives of EWS SR4. Arg residues are highlighted in blue and adjacent Asp residues in red. Ser residues c-terminal to Arg and Asp to Ala changes in T15DA are highlighted in black. In addition to the reporter required for the 2-hybrid assay (Zta-CAT) cells were co-transfected with a Gal4 reporter (G4-Cat) for general functional verification of all test proteins. PRMT1 binding is represented quantitatively by the relative Zta-Cat/G4-Cat reporter activity with SR4 set at 100% (below autoradiogram of CAT assay) or semi-quantitatively to the right of each polyRGG variant.
while we have not assessed the methylation state of TAF15 in vivo, given the magnitude of the in vivo substrate binding effects observed (the binding of PRMT1 to TAF15 YGGDR(S/G)G repeats is 3% of that for SR4 peptide, determined in the 2-hybrid assay) it seems unlikely that such a poor interaction would lead to efficient methylation. Second, although some PRMT-binding proteins can reportedly change PRMT substrate specificity 11 this possibility also seems unlikely given the structural models for PRMT1/RGG-box interaction (see below). Third, based on our results and also the conserved features of PRMTs, 11 it also seems unlikely that PRMTs other than PRMT1 might be responsible for methylation of TAF15 YGGDR(S/G)G repeats reported in vivo.
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Perhaps therefore it is most likely that although many TAF15 RGG-boxes are methylated 17 the degree of methylation for individual sites may be somewhat low, reflecting weak interactions with PRMT1. This possibility may be supported by the observation that TAF15 methylation appears to be significantly weaker (per Arg residue) than methylation of Histone H4 Arg3. Thus, PRMT1-dependent TAF15 methylation observed in vivo 17 may be accounted for by significant methylation within the TAF15 C6 peptide (see Fig. 1 ) and low levels of methylation for numerous other TAF15 RGG-boxes including those present in YGGDR(S/G)G repeats. Similar to many other PRMT1 targets, FET proteins have a large number of Arg residues that are methylated but whether a high degree of methylation is required for FET protein function is unknown. For the hnRNP-like yeast protein Npl3, cumulative methylation is important for several functions. 33 This raises the possibility that reduced overall methylation of TAF15 (due to weak methylation of YGGDR(S/G)G sites) would be sufficient to functionally differentiate TAF15 from EWS/FUS.
A dynamic polyelectrostatic model for capture of polyRGG substrates by PRMT1
Previous studies have suggested a mechanism for substrate binding by PRMT1 involving electrostatic attraction between positively charged polyRGG substrates and negative surface charges on PRMT1. 20 Lack of binding by polyRGG substrates with overall neutral charge (including T15R, C2-C4, EPYD, and EPGD in the current study), supports the above mechanism. The nature of the proposed electrostatic attraction has, however, yet to be elaborated. Herein, we propose that poly-RGG/PRMT1 binding occurs via a so called "fuzzy" interaction 34 in which the polyvalent ligand (polyRGG) exhibits a dynamic ensemble of disordered bound states (Fig. 4) . Such interactions were originally described for binding between the cell cycle regulators Cdc4 and Sic1 35 and later for the Ewings Sarcoma (EWS) Activation Domain (EAD)/rpb7 complex. 36 Several observations herein and previously (20) (21) (22) are compatible with a highly dynamic interaction between polyRGG substrates and PRMT1. First, specific contacts outside of the active site in the polyRGG/PRMT1 co-crystals are poorly defined 20 and this is a hallmark of fuzzy interactions. Second, polyRGG substrates are highly disordered 6 and could readily engage in flexible polyelectrostatic interactions. Third, the diversity of substrates (11) and loose definition of PRMT1 substrate binding channels 20 offer no indication of significant geometric constraints that would apply to a more static polyvalent interaction. Fourth, only four of 19 negatively charged surface residues on PRMT1 impact substrate binding 22 and this is insufficient for an extensive stoichiometric interaction with polyRGG substrates.
Given that PRMT1 has a relative abundance of exposed aromatic residues, it is also plausible, a priori, that polyRGG/PRMT1 binding could be achieved via polycation-p interactions, similar to those that mediate EAD/rpb7 interaction. 36 However in the case of EAD/rpb7, intramolecular cation-p contacts in the disordered EAD (introduced experimentally) prevent binding to rpb7 via competition with the intermolecular contacts that drive binding. 36 In contrast several polyRGG substrates (EFY, EPY, and T15DA) contain equimolar amounts of Tyr and Arg and yet bind well to PRMT1 (Figs. 3 and 4) . In light of studies of EAD/rpb7 36 this latter finding argues against a polycation-p mediated interaction for polyRGG/PRMT1. In the future, computational approaches that have been exploited for the study of polyvalent fuzzy interactions, 35, 36 should facilitate a detailed biophysical interrogation of the proposed model for polyRGG/PRMT1 interaction.
Functional differentiation of FET family members
Expansion, mutation, and transposition of repetitive sequences is particularly significant for evolution of novel functions in Intrinsically Disordered Protein Regions. 37 While several functions of RGG-boxes are maintained in all FET proteins, 2,3 RGG-boxes present with TAF15 YGGDR(S/G)G repeats can be distinguished from other FET RGG-boxes by their inability to mediate FET transcriptional auto-repression. 10 Herein, we present evidence that such functional differentiation extends to interaction with PRMT1. Considering the prevalence of YGGDR(S/ G)G repeats and their specific enrichment in TAF15 [ Fig. 1(A) ], our experimental findings further support the possibility YGGDR(S/G)G repeats may contribute to biological specialization of TAF15. RGG-boxes mediate RNA-protein and proteinprotein interactions 9 and although a large number of such interactions are not affected by methylation, 38 the role of Arg methylation in protein-interactions is recognized in other systems. 39 Given our results it seems likely that reduced levels of TAF15 methylation might allow differential interactions between FET family members and some of their protein or RNA partners.
Materials and methods
Plasmids. p-GexPRMT1 was derived from pGex-2T 40 and expresses full length PRMTI fused to glutathione S-transferase. pETG4VP16 was derived from pET15b (Promega) and expresses a his-tagged Gal4VP16 fusion protein (G4VP16) corresponding to that used for previous in vivo studies. 29 Plasmids containing reiterated RGG rich motifs were constructed via commercial gene synthesis of the RGG rich sequences flanked by terminal restriction enzyme sites to enable insertion into the required vector. pETG4VPSR4 expresses a his-tagged Gal4VP16 fusion (G4VPSR4) containing 16 RGG boxes present in four copies of the SR4 peptide (Fig. 2) from the RGG3 region of EWS. 29 For pETG4VPSRM1, the reiterated SR4 peptide is replaced by the SRm1 thus changing all Arg residues to Ala. 29 Similarly, pETRGG1, pETT15R, pETRD, pETC1, pETC5, pETC6, and pETC7 correspond to pETG4VPSR4 with the RGG-related peptide sequences described Figure 1 and Materials and Methods. The integrity of all constructs was verified by DNA sequencing and detection of a c-terminal 7-residue KT3 epitope 41 by Western Blotting using KT3
antibody.
For in vivo two-hybrid assays in mammalian cells, transcriptional reporters pG1E4TCAT 42 and pZ7E4T-CAT 43 were as previously described. pPRMT1Z expresses full length PRMT1 fused to ATFl 1-210 and the bZIP domain of Zta (residues 150-245) as previously described.
44 pESR4 was derived from pEGFP-C1
(Clontech) and expresses an EGFP-fusion protein containing the VP16 transcriptional activation domain, the EWS transcriptional activation domain (EAD) and four copies of RGG enriched SR4 peptide (see Fig. 2 ). pESRm1, pESRm2, and pESRm3 are identical to pESR4 except for the changes within RGG boxes as follows: pESRm1 (all Arg residues within SR4 peptide changed to Ala), pESRm2 (all Arg residues within SR4 peptide changed to Lys) and pESRm3 (both Phe residues within SR4 peptide changed to Ala). pVPESR4 29 expresses a fusion containing the Gal4 DNA-binding-domain, the VP16 transcriptional activation domain, the EWS transcriptional activation domain (EAD) and four copies of RGG enriched SR4 peptide. pSR2, pT15R, pT15DA, pC2, pC3, pC4, pEFY, pEPY, pEPYD, pEPGD, and pERS correspond to pVPESR4 with the RGG box mutations or substitutions (relative to the SR4 peptide) shown in Figure 3 . DNA fragments containing the desired RGG box variants were obtained by commercial gene synthesis followed by insertion into pVPESR4 to replace the SR4 peptide encoding sequences. All constructs were verified by DNA-sequencing and expression of full-length proteins containing the c-terminal KT3 epitope.
RGG rich peptide sequences. SR4 peptide contains EWS residues 587-604 from the RGG3 region of EWS (see Figs. 1 and 2 ). SRm1-3 peptides correspond to SR4 with the mutations shown in Figure 2 . Similarly, EFY, EPY, EPYD, EPGD, and ERS are altered versions of SR4 (Fig. 3) . SR2 peptide contains EWS residues 303-325 from the RGG1 region of EWS (see Fig. 1 ). Location of TAF15 peptides T15R and C2-C7 within the TAF15 RBD are as follows. C5 (TAF15 residues 159-219); C6 (316-349); C7 (377-413); C2 (414-451); C3 (459-490); T15R (491-518); C4 (527-562). RD peptide contains TAF15 peptides C5-C7 in the same order as native TAF15 (C5 at the n-terminus). T15DA corresponds to T15R with all Asp residues changed to Ala.
Purification of affinity-tagged proteins. All proteins were expressed in bacterial strain BL21(DE3) and extracted and purified on ice as described elsewhere. 25 For Gst-PRMT1, cells from 50 mL of induced p-GexPRMT1 culture were resuspended in 4 mL of Lysis Buffer (1M NaCl, 0.5% Triton X-100 in PBS)] and lysed by sonication. The lysate was clarified by centrifugation at 14,000 rpm for 15 minutes in an Eppendorf microfuge and the supernatant mixed with 150 lL of glutathione Sepharose 4B (GE Healthcare) for 1 hour. The supernatant was removed and the Gst-PRMT1 resin washed with 30ml of Lysis Buffer. 10 lL of resin was set aside for SDS gel analysis to confirm bound Gst-PRMT1 (1 lg/10 lL resin) by Coomassie Blue RT250 staining and comparison with a known BSA standard. The remainder of the resin was then used immediately for pull-down assays. Histidine-tagged G4VP16 derivatives (containing test RGG variants/mutants) were purified from extracts made from 300ml of bacterial culture, using 200lL Ni-affinity resin (NTA, Qiagen) as previously described. 25 Purified proteins were eluted with buffer containing 100 mM imidazole, 10 mM tris pH 8.0 and 20% glycerol and then adjusted to obtain a purified protein concentration of 100 ng/lL. Protein concentrations were adjusted by dilution with elution buffer or concentration using a centrifugal filter with a cutoff of 10 kDa (Ultracel YM-10 Millipore).
Pull-down and methylation assays. For pulldown and methylation assays, reactions at room temperature contained 10 lL of Gst-PRMT1 resin (1 lg Gst-PRMT1) and 10 lL (1 lg) his-tagged protein, adjusted to 50 lL total volume with Lysis Buffer containing 100 mM NaCl and 5 lL S-adenosyl-L-[methyl- 
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Concentration of polyRGG substrates was 0.65 mM and thus sub saturating given the Km of 4.2 mM for other substrates. 46 Samples were mixed at room temperature for 2 hours, supernatants removed and residual unbound proteins removed by briefly washing twice with 1 mL of Lysis Buffer containing 100 mM NaCl. Resin containing bound/methylated proteins was immediately prepared for SDS/PAGE by addition of SDS sample buffer and boiling for 2 minutes. Gels were then bathed in EN3Hance autoradiography Enhancer (Perkin Elmer Life Sciences) for 30 minutes, washed in water for 60 minutes, dried and exposed to x-ray film for 1-3 days.
Mammalian cell 2-hybrid assays. Jeg3 cells were grown in Dulbecco's modification of Eagles medium containing 10% FCS. Freshly passaged cells were transfected by calcium phosphate coprecipitation method 47 using 5 lg of reporter plasmid (pZ7E4TCAT or pG1E4TCAT), 5 lg of pPRMT1Z as bait and 5 lg of prey plasmid containing RGG box variants. CAT assays and Western Blotting of epitope-tagged proteins were carried out as previously described. 48 CAT assays in Figure 3 were quantified by cutting out the spots from the TLC plate, counting in a scintillation counter and calculating % conversion in the linear range. CAT assays in Figure 2 and some in Figure 3 were not quantified due to the magnitude of the differences. Multiple experiments were carried out with all mutants being tested at least three times, referenced in each case by comparison with a positive control peptide (SR4 or SR2)
